Sign In
Buy BPTH
$0.0300
+0.0066 (+28.21%)
At Close: Jun 03, 2026
Bio-Path Holdings to Announce Second Quarter 2020 Financial Results on August 14, 2020
12:00pm, Friday, 07'th Aug 2020
HOUSTON, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ:BPTH)
11:30am, Wednesday, 17'th Jun 2020
DALLAS, TX / ACCESSWIRE / June 17, 2020 / Bio-Path Holdings, Inc. (NASDAQ:BPTH). The full report can be accessed by clicking on the following link: http://stonegateinc.com/reports/BPTH%20JUNE%202020.p
Bio-Path Holdings Highlights Presentations At 2020 ASCO Annual Meeting
12:28pm, Friday, 29'th May 2020Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting
12:00pm, Friday, 29'th May 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, tod
Bio-Path shares are trading higher after HC Wainwright & Co maintained its Buy rating on the stock.
01:00pm, Monday, 18'th May 2020HC Wainwright & Co. Reiterates Buy on Bio-Path Holdings, Lowers Price Target to $18
11:28am, Monday, 18'th May 2020Edited Transcript of BPTH earnings conference call or presentation 15-May-20 12:30pm GMT
11:11pm, Friday, 15'th May 2020
Q1 2020 Bio Path Holdings Inc Earnings Call
Bio-Path Holdings Q1 EPS $(0.900) Misses $(0.670) Estimate
11:05am, Friday, 15'th May 2020Bio-Path Holdings Reports First Quarter 2020 Financial Results
11:00am, Friday, 15'th May 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drug
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
12:00am, Friday, 15'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 14)
Allogene Therapeutics Inc (...
Bio-Path Highlights Upcoming Presentation On DNAbilize At ASCO May 29
09:20pm, Wednesday, 13'th May 2020Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
09:00pm, Wednesday, 13'th May 2020
HOUSTON, May 13, 2020 -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to.
